Indo Us Bio Tech Ltd vs Jay Kailash Namkeen Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Sep 27, 2026

Key Highlights

The Latest Trading Price of Indo US Bio-Tech Ltd is ₹ 80.5 as of 25 Sep 15:30 . The P/E Ratio of Indo US Bio-Tech Ltd is 4 as of March 2021 .The P/E Ratio of Jay Kailash Namkeen Ltd is 0 as of March 2021 . The Market Cap of Indo US Bio-Tech Ltd is ₹ 19.75 crore as of March 2021 .The Market Cap of Jay Kailash Namkeen Ltd is ₹ 0 crore as of March 2021 . The revenue of Indo US Bio-Tech Ltd for the Jun '26 is ₹ 33.11 crore as compare to the Mar '26 revenue of ₹ 26.05 crore. This represent the growth of 27.1% The revenue of Jay Kailash Namkeen Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Indo US Bio-Tech Ltd for the Jun '26 is ₹ 4.09 crore as compare to the Mar '26 ebitda of ₹ 3.25 crore. This represent the growth of 25.85% The ebitda of Jay Kailash Namkeen Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Indo US Bio-Tech Ltd changed from ₹ 3.17 crore to ₹ 3.04 crore over 9 quarters. This represents a CAGR of -1.84% The net profit of Jay Kailash Namkeen Ltd changed from ₹ 0 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of 0.0% The Dividend Payout of Indo US Bio-Tech Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Jay Kailash Namkeen Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Indo US Bio-Tech Ltd

Indo Us Bio-Tech Limited was originally incorporated as 'Pollucid Bio-Tech Private Limited' at Junagadh on February 4, 2004.
Subsequently, the name was change to 'Pellucid Bio-Tech Private Limited' on January 5, 2005.
Later on, the name of the Company was changed to 'Indo Us Bio-Tech Private Limited' on March 9, 2007.
Consequently, upon conversion into Public Limited Company, the name of the Company was changed to 'Indo Us Bio-Tech Limited' on January 11, 2018. The Company is an ISO 9001-2008 company, involved in crop research & development throw breeding, production of seeds, processing, packing and marketing of high performing hybrid and open pollinated varieties of agricultural crops.
The Company has its seed processing plants located in Gujarat, where the seeds are processed, stored and packed with the help of modern machineries.

About Jay Kailash Namkeen Ltd

Jay Kailash Namkeen Limited was originally incorporated on June 30, 2021 as 'Jay Kailash Namkeen (OPC) Private Limited' with the RoC.
Subsequently, Company had acquired the ongoing business of Proprietorship Firm, 'M/s.
Kailash Namkeen' via Business Transfer Agreement dated July 26, 2021, which changed the name of the Company to 'Jay Kailash Namkeen Private Limited' on May 25, 2022.
Finally, the status was converted into Public Company as 'Jay Kailash Namkeen Limited' vide fresh Certificate of Incorporation dated June 24, 2022 issued by the Registrar of Companies, Ahmedabad. Prior to incorporation of the Company, 'M/s.
Kailash Namkeen', a Proprietorship Firm, was founded by Nishitbhai Navinbhai Sonchhatra, which engaged in the business of manufacturing Namkeen in Rajkot, Gujarat.

FAQs for the comparison of Indo US Bio-Tech Ltd and Jay Kailash Namkeen Ltd

Which company has a larger market capitalization, Indo US Bio-Tech Ltd or Jay Kailash Namkeen Ltd?

Market cap of Indo US Bio-Tech Ltd is 161 Cr while Market cap of Jay Kailash Namkeen Ltd is 28 Cr

What are the key factors driving the stock performance of Indo US Bio-Tech Ltd and Jay Kailash Namkeen Ltd?

The stock performance of Indo US Bio-Tech Ltd and Jay Kailash Namkeen Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Indo US Bio-Tech Ltd and Jay Kailash Namkeen Ltd?

As of September 27, 2026, the Indo US Bio-Tech Ltd stock price is INR ₹80.5. On the other hand, Jay Kailash Namkeen Ltd stock price is INR ₹57.95.

How do dividend payouts of Indo US Bio-Tech Ltd and Jay Kailash Namkeen Ltd compare?

To compare the dividend payouts of Indo US Bio-Tech Ltd and Jay Kailash Namkeen Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.